2:basal treatment

3 trials

Sponsors

Jixian People's Hospital of Tianjin, Peking University People's Hospital

Conditions

angiocardiopathyhematolgical maligance

Phase 1

Clinical trial of megakaryocyte progenitor generated from cord blood to treat thrombocytopenia after chemotherapy or radiotherapy of hematolgical maligance

Active, not recruitingChiCTR-TRC-11001691

Peking University People's Hospitalhematolgical maligance

Start: 2011-06-14Updated: 2017-04-18

Clinical trial of erythroid progenitor cell injection generated from cord blood to treat anemia after chemotherapy or radiotherapy of hematolgical maligance

Active, not recruitingChiCTR-TRC-11001741

Peking University People's Hospitalhematolgical maligance

Start: 2011-06-14Updated: 2017-04-18

Phase 4

Clinical study of sequential therapy for refractory heart failure with vasodilator

Active, not recruitingChiCTR-IPR-16009291

Jixian People's Hospital of Tianjinangiocardiopathy

Start: 2012-03-01Updated: 2017-04-18

Related Papers

233. The Efficacy of Megakaryocytic Progenitor Products Generated from Cord Blood in Acute Myeloid Leukemia Patients: A Before-After Phase 2 Trial

Molecular Therapy2016-05-01